Unique ID issued by UMIN | UMIN000015389 |
---|---|
Receipt number | R000017753 |
Scientific Title | Potential detectability of blood flow in hepatocellular carcinoma using contrast-enhanced ultrasonography with Sonazoid (Comparison with transvenous contrast-enhanced computed tomography or computed tomography with angiography) |
Date of disclosure of the study information | 2014/10/10 |
Last modified on | 2015/10/26 15:54:30 |
Potential detectability of blood flow in hepatocellular carcinoma using contrast-enhanced ultrasonography with Sonazoid (Comparison with transvenous contrast-enhanced computed tomography or computed tomography with angiography)
Potential detectability of tumor blood flow using contrast-enhanced ultrasonography
Potential detectability of blood flow in hepatocellular carcinoma using contrast-enhanced ultrasonography with Sonazoid (Comparison with transvenous contrast-enhanced computed tomography or computed tomography with angiography)
Potential detectability of tumor blood flow using contrast-enhanced ultrasonography
Japan |
Hepatocellular carcinoma
Hepato-biliary-pancreatic medicine |
Malignancy
NO
To evaluate the efficacy of the findings of tumor blood flow using contrast-enhanced ultrasonography by comparison with transvenous contrast-enhanced computed tomography or computed tomography with angiography
Efficacy
Potential detectability of tumor blood flow using contrast-enhanced ultrasonography, intravenous contrast-enhaced computed tomography, and computed tomography with angiography
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Diagnosis
Medicine |
Microbubble contrast agents; Sonazoid
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1. Presence of suspected hepatocellular carcinomas of 30 mm in size or less by ultrasonography
2. Patients who were able to conduct the examinations within two weeks; intravenous contrast-enhanced computed tomography, computed tomography with angiography, and contrast-enhanced ultrasonography
3. Having received adequate explanation of the contents of the trial and given their written consent
1. Egg allergy
2. Severe lung disease
3. Severe heart disease
4. Hepatocellular carcinomas are not supplied by hepatic artery.
5. Tumors are diagnosed not to be hepatocellular carcinomas.
6. Determined to be ineligible by the physician in charge for any other reason.
100
1st name | |
Middle name | |
Last name | Hitoshi Maruyama |
Chiba University Graduate School of Medicine
Department of Gastroenterology and Nephrology
1-8-1, Inohana, Chuou-ku, Chiba, Japan
043-226-2083
maru-cib@umin.ac.jp
1st name | |
Middle name | |
Last name | Hitoshi Maruyama |
Chiba University Graduate School of Medicine
Department of Gastroenterology and Nephrology
1-8-1, Inohana, Chuou-ku, Chiba, Japan
043-226-2083
maru-cib@umin.ac.jp
Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology
Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology
Self funding
NO
2014 | Year | 10 | Month | 10 | Day |
Unpublished
Completed
2008 | Year | 06 | Month | 18 | Day |
2008 | Year | 07 | Month | 01 | Day |
2014 | Year | 10 | Month | 09 | Day |
2015 | Year | 10 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017753
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |